Dermoscribe Seborrheic Dermatitis Cream
FDA Label NDC 69683-202

8 label sections · Submitted to the FDA by Dermoscribe Pty Ltd · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Dermoscribe Pty Ltd for the product Dermoscribe Seborrheic Dermatitis (NDC 69683-202). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, use, warnings, otc - keep out of reach of children, directions, inactive ingredients, recent major changes, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Active Ingredients

Sulfur 3%, Salicylic Acid 3%, Hydrocortisone 1%

Purpose

SEBORRHEIC DERMATITIS CREAM

Use

For relief of itching, scaling, redness, flaking and irritation associated with seborrheic dermatitis

Warnings

FOR EXTERNAL USE ONLY.

Ask a doctor before use if condition covers a large area of the body

When using this product avoid contact with eyes. If contact occurs, rinse eye thoroughly with water

Stop use and consult a doctor if condition worsens or does not improve after regular use as directed

Otc - Keep Out Of Reach Of Children

KEEP OUT OF REACH OF CHILDREN. If swallowed, seek medical advice or contact a Poison Control Center immediately

Directions

Apply to affected area once or twice daily

Inactive Ingredients

Aloe Oil, Carbomer, Ceteryl Alcohol, Coconut Oil, Extract of Aloe Vera, Glycerine, Glycol Sterate, Grapefruit Seed Extract, Polysorbate 20, Purified Water, Sodium Hydroxide, Sorbitol

* Please review the disclaimer below.